Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results

Quince Therapeutics, Inc. , a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease therapeutics,...

Related Keywords

Dirk Thye ,Us Food Drug Administration ,Exchange Commission ,International Cooperative Ataxia Rating Scale Rm ,Quince Therapeutics Inc ,Nasdaq ,Facebook ,Securities Exchange ,Linkedin ,Quince Therapeutics ,Chief Executive Officer ,Chief Medical ,Autologous Intracellular Drug Encapsulation ,Neurologic Effects ,Special Protocol Assessment ,Drug Administration ,International Cooperative Ataxia Rating Scale ,Cash Position Expected ,Support Meaningful Clinical ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Quarterly Report ,Markets ,